Skip to search formSkip to main contentSkip to account menu

ONO 4817

Known as: ONO-4817, ONO4817 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
queous zymography screening of matrix metalloproteinase activity and nhibition based on colorimetric gold nanoparticles ao
An optical gold nanoparticles (AuNPs)-based method was fabricated for the rapid detection of matrix metalloproteinase (MMP… 
2004
2004
MATRIX METALLOPROTEINASE INHIBITOR (ONO-4817) ATTENUATES ISCHEMIA-REPERFUSION INJURY IN AN ISOLATED RAT LUNG
2003
2003
Suppression of Active Experimental Autoimmune Encephalomyelitis in Lewis Rats by Using Compound ONO-4817, a New Inhibitor of Matrix Metalloproteinases
Objective To explore the clinical effects of ONO-4817, a new synthetic hydroxamic acid-based combined inhibitor of matrix… 
2003
2003
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice
2003
2003
ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant model
2003
2003
Local Delivery of Low-Dose ONO-4817, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, Reduces Neointimal Hyperplasia Coupled with Decreased Collagen Deposition
2003
2003
Oral Administration of Matrix Metalloproteinase (MMP) Inhibitor ONO-4817 Blocks Left Ventricular (LV) Remodeling in Rats with Salt-Sensitive Hypertension
2001
2001
Inhibition of cervical lymphnode metastasis of tongue squamous cell carcinoma by the matrix metalloproteinase inhibitor ONO-4817
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)